Clinical challenges in managing bronchiectasis series

Respirology

Volumn 14, Issue 5, 2009, Pages 637-650

  Tsang, Kenneth W ^a   Bilton, Diana ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

Bronchiectasis; Immunomodulation; Infection; Inflammation; Lytic enzymes

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTITUSSIVE AGENT; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA LACTAM ANTIBIOTIC; BUDESONIDE; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; COLISTIN; CORTICOSTEROID; ELASTASE; ERYTHROMYCIN; FLUTICASONE; INFLUENZA VACCINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVOFLOXACIN; MACROLIDE; MATRIX METALLOPROTEINASE; MUCOLYTIC AGENT; PLACEBO; PNEUMOCOCCUS VACCINE; PREDNISOLONE; TOBRAMYCIN;

ANTIBIOTIC THERAPY; ASTHMA; BIOFILM; BLEEDING; BREATHING EXERCISE; BRONCHIECTASIS; BRONCHIOLITIS; BRONCHOSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; ENZYME ACTIVITY; ENZYME RELEASE; EUKARYOTIC FLAGELLUM; GLUCOSURIA; HAEMOPHILUS INFLUENZAE; HEMOPTYSIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMMUNOMODULATION; INFLAMMATION; INFLUENZA; LONG TERM CARE; LOW DRUG DOSE; LUNG FIBROSIS; LUNG TRANSPLANTATION; MAINTENANCE THERAPY; NONHUMAN; NUTRITION; OXYGEN THERAPY; PANBRONCHIOLITIS; PATHOGENESIS; PNEUMOCOCCAL INFECTION; PNEUMOTHORAX; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULMONARY REHABILITATION; RESPIRATORY FAILURE; RESPIRATORY TRACT INFECTION; REVIEW; SMOKING CESSATION; SPUTUM ANALYSIS; STREPTOCOCCUS PNEUMONIA; TENDON RUPTURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; BRONCHIECTASIS; HUMANS; IMMUNOLOGIC FACTORS; TREATMENT OUTCOME;

EID: 68149152145     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2009.01569.x     Document Type: Review

References (173)

1. Tsang KW, Tipoe GL. Bronchiectasis: not an orphan disease in the east. Int. J. Tuberc. Lung Dis. 2004 8 : 691 702.
2. King P. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis? Drugs 2007 67 : 965 74.
3. Lazarus A, Myers J, Fuhrer G. Bronchiectasis in adults: a review. Postgrad. Med. 2008 120 : 113 21.
4. O'Donnell AE. Bronchiectasis. Chest 2008 134 : 815 23.
5. Bilton D. Update on non-cystic fibrosis bronchiectasis. Curr. Opin. Pulm. Med. 2008 14 : 595 9.
6. Ilowite J, Spiegler P, Chawla S. Bronchiectasis: new findings in the pathogenesis and treatment of this disease. Curr. Opin. Infect. Dis. 2008 21 : 163 7.
7. Boren EJ, Teuber SS, Gershwin ME. A review of non-cystic fibrosis pediatric bronchiectasis. Clin. Rev. Allergy Immunol. 2008 34 : 260 73.
8. Tsang KW. Solutions for difficult diagnostic cases of acute exacerbations of chronic bronchitis. Chemotherapy 2001 47 (Suppl. 4 S28 38 discussion S53-4.
9. Edwards EA, Asher MI, Byrnes CA. Paediatric bronchiectasis in the twenty-first century: experience of a tertiary children's hospital in New Zealand. J. Paediatr. Child Health 2003 39 : 111 17.
10. Chan-Yeung M, Lai CK, Chan KS, Cheung AH, Yao TJ et al. The burden of lung disease in Hong Kong: a report from the Hong Kong Thoracic Society. The burden of lung disease in Hong Kong. Respirology 2008 13 (Suppl. 4 S133 65.
11. Pasteur MC, Helliwell SM, Houghton SJ, Webb SC, Foweraker JE et al. An investigation into causative factors in patients with bronchiectasis. Am. J. Respir. Crit. Care Med. 2000 162 : 1277 84.
12. Tsang KW, Lam SK, Lam WK, Karlberg J, Wong BC et al. High seroprevalence of Helicobacter pylori in active bronchiectasis. Am. J. Respir. Crit. Care Med. 1998 158 : 1047 51.
13. Zheng L, Shum H, Tipoe GL, Leung R, Lam WK et al. Macrophages, neutrophils and tumour necrosis factor-alpha expression in bronchiectatic airways in vivo. Respir. Med. 2001 95 : 792 8.
14. Zheng L, Lam WK, Tipoe GL, Shum IH, Yan C et al. Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo. Eur. Respir. J. 2002 20 : 170 6.
15. Tsang KW, Ho PL, Lam WK, Ip MS, Chan KN et al. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. Am. J. Respir. Crit. Care Med. 1998 158 : 723 7.
16. Lapa e Silva JR, Guerreiro D, Noble B, Poulter LW, Cole PJ. The immunological component of the cellular inflammatory infiltrate in bronchiectasis. Thorax 1989 44 : 668 73.
17. Fenlon HM, Doran M, Sant SM, Breatnach E. High-resolution chest CT in systemic lupus erythematosus. AJR Am. J. Roentgenol. 1996 166 : 301 7.
18. Tsui LC. Population analysis of the major mutation in cystic fibrosis. Hum. Genet. 1990 85 : 391 2.
19. Goodchild MC, Insley J, Rushton DI, Gaze H. Cystic fibrosis in Pakistani children. Arch. Dis. Child. 1974 49 : 739 41.
20. Kabra M, Kabra SK, Ghosh M, Khanna A, Arora S et al. Is the spectrum of mutations in Indian patients with cystic fibrosis different? Am. J. Med. Genet. 2000 93 : 161 3.
21. Maddalena A, Bick DP, Fugger E, Jones S, Schulman JD. Screening of sperm bank donors for the delta-F508 cystic fibrosis mutation. Am. J. Hum. Genet. 1990 47 : A290.
22. Tsang KW, Tipoe GL, Zheng L. Ciliary assessment in bronchiectasis. Respirology 2000 5 : 91 8.
23. Tsang KW, Ip M, Ooi CG, Wong MP, Ho CS et al. Kartagener's syndrome: a re-visit with Chinese perspectives. Respirology 1998 3 : 107 12.
24. Kroon AA, Heij JM, Kuijper WA, Veerman AJ, van der Baan S. Function and morphology of respiratory cilia in situs inversus. Clin. Otolaryngol. 1991 16 : 294 7.
25. Tsang KW, Tipoe G, Sun J, Ho JC, Lam B et al. Severe bronchiectasis in patients with 'cystlike' structures within the ciliary shafts. Am. J. Respir. Crit. Care Med. 2000 161 : 1300 5.
26. Tsang KWT. Diffuse panbronchiolitis: diagnosis and treatment. Clin. Pulm. Med. 2000 7 : 245 52.
27. She J, Sun Q, Fan L, Qin H, Bai C et al. Association of HLA genes with diffuse panbronchiolitis in Chinese patients. Respir. Physiol. Neurobiol. 2007 157 : 366 73.
28. Tsang KW, Ooi CG, Ip MS, Lam WK, Ngan H et al. Clinical profiles of Chinese patients with diffuse panbronchiolitis. Thorax 1998 53 : 274 80.
29. Kudoh S, Uetake T, Hagiwara K, Hirayama M, Hus LH et al. Clinical effects of low dose long term erythromycin chemotherapy of diffuse panbronchiolitis. Nihon Kyobu Shikkan Gakkai Zasshi 1987 25 : 632 42.
30. Nakata H, Kimoto T, Nakayama T, Kido M, Miyazaki N et al. Diffuse peripheral lung disease: evaluation by high resolution computed tomography. Radiology 1985 157 : 181 5.
31. Fujii T, Kadota J, Kawakami K, Iida K, Shirai R et al. Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection. Thorax 1995 50 : 1246 52.
32. Shi G, Bruley des Varannes S, Scarpignato C, Le Rhun M, Galmiche JP. Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 1995 37 : 457 64.
33. Hu WHC, Hui WM, Lam SK. Anxiety and depression are co-factors determining health care utilization in patients with dyspepsia: a Hong Kong population based study. Gastroenterology 1997 112 : A153.
34. Ayres JG, Miles JF. Oesophageal reflux and asthma. Eur. Respir. J. 1996 9 : 1073 8.
35. Tolia V, Vandenplas Y. Systematic review: the extra-oesophageal symptoms of gastro-oesophageal reflux disease in children. Aliment. Pharmacol. Ther. 2009 29 : 258 72.
36. Tsang KW, Lam WK, Kwok E, Chan KN, Hu WH et al. Helicobacter pylori and upper gastrointestinal symptoms in bronchiectasis. Eur. Respir. J. 1999 14 : 1345 50.
37. DeMeester TR, Wang CI, Wernly JA, Pellegrini CA, Little AG et al. Technique, indications, and clinical use of 24 h esophageal pH monitoring. J. Thorac. Cardiovasc. Surg. 1980 79 : 656 70.
38. Chen CH, Lai CL, Tsai TT, Lee YC, Perng RP. Foreign body aspiration into the lower airway in Chinese adults. Chest 1997 112 : 129 33.
39. Ho JC, Ooi GC, Lam WK, Lam B, Cheung TF et al. Endobronchial actinomycosis associated with a foreign body. Respirology 2000 5 : 293 6.
40. Adegboye VO, Osinowo O, Adebo OA. Bronchiectasis consequent upon prolonged foreign body retention. Cent. Afr. J. Med. 2003 49 : 53 8.
41. Karakoc F, Cakir E, Ersu R, Uyan ZS, Colak B et al. Late diagnosis of foreign body aspiration in children with chronic respiratory symptoms. Int. J. Pediatr. Otorhinolaryngol. 2007 71 : 241 6.
42. Ooi GC, Khong PL, Müller NL, Yiu WC, Zhou LJ et al. Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients. Radiology 2004 230 : 836 44.
43. Travis WD, Hunninghake G, King TE Jr., Lynch DA, Colby TV et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project Published erratum appears in Am. J. Respir. Crit. Care Med. 2008; 178: 211 Am. J. Respir. Crit. Care Med. 2008 177 : 1338 47.
44. Gunn ML, Godwin JD, Kanne JP, Flowers ME, Chien JW. High-resolution CT findings of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. J. Thorac. Imaging 2008 23 : 244 50.
45. Morehead RS. Bronchiectasis in bone marrow transplantation. Thorax 1997 52 : 392 3.
46. Philit F, Wiesendanger T, Archimbaud E, Mornex JF, Brune J et al. Post-transplant obstructive lung disease ('bronchiolitis obliterans'): a clinical comparative study of bone marrow and lung transplant patients. Eur. Respir. J. 1995 8 : 551 8.
47. Vergnenègre A, Pugnere N, Antonini MT, Arnaud M, Melloni B et al. Airway obstruction and rheumatoid arthritis. Eur. Respir. J. 1997 10 : 1072 8.
48. Eaton TE, Lambie N, Wells AU. Bronchiectasis following colectomy for Crohn's disease. Thorax 1998 53 : 529 31.
49. Nowack C, Held M, Costabel U. 61-year-old patient with bronchiectasis, vitiligo and chronic atrophic gastritis. Internist (Berl) 1998 39 : 860 5.
50. Shneerson JM. Lung bullae, bronchiectasis, and Hashimoto's disease associated with ulcerative colitis treated by colectomy. Thorax 1981 36 : 313 14.
51. Verghese A, al-Samman M, Nabhan D, Naylor AD, Rivera M. Bacterial bronchitis and bronchiectasis in human immunodeficiency virus infection. Arch. Intern. Med. 1994 154 : 2086 91.
52. Chotirmall SH, Branagan P, Gunaratnam C, McElvaney NG. Aspergillus/allergic bronchopulmonary aspergillosis in an Irish cystic fibrosis population: a diagnostically challenging entity. Respir. Care 2008 53 : 1035 41.
53. Ho PL, Lam WK, Ip MSM, Chan KN, Yuen KY et al. The effects of Pseudomonas aeruginosa infection in clinical parameters in steady state bronchiectasis. Chest 1998 114 : 1623 9.
54. Tsang KW, Rutman A, Kanthakumar K, Belcher J, Lund V et al. Haemophilus influenzae infection of human respiratory mucosa in low concentrations of antibiotics. Am. Rev. Respir. Dis. 1993 148 : 201 7.
55. Tsang KW, Rutman A, Tanaka E, Lund V, Dewar A et al. Interaction of Pseudomonas aeruginosa with human respiratory mucosa in vitro. Eur. Respir. J. 1994 7 : 1746 53.
56. Starner TD, Zhang N, Kim G, Apicella MA, McCray PB Jr. Haemophilus influenzae forms biofilms on airway epithelia: implications in cystic fibrosis. Am. J. Respir. Crit. Care Med. 2006 174 : 213 20.
57. Zheng L, Tipoe G, Lam WK, Ho JC, Shum I et al. Endothelin-1 in stable bronchiectasis. Eur. Respir. J. 2000 16 : 146 9.
58. Zheng L, Tipoe G, Lam WK, Leung RY, Ho JC et al. Up-regulation of circulating adhesion molecules in bronchiectasis. Eur. Respir. J. 2000 16 : 691 6.
59. Stockley RA. Neutrophils and protease/antiprotease imbalance. Am. J. Respir. Crit. Care Med. 1999 160 : S49 52.
60. Chan SC, Shum DK, Ip MS. Sputum sol neutrophil elastase activity in bronchiectasis: differential modulation by syndecan-1. Am. J. Respir. Crit. Care Med. 2003 168 : 192 8.
61. Evans DJ, Greenstone M. Long-term antibiotics in the management of non-CF bronchiectasis - do they improve outcome? Respir. Med. 2003 97 : 851 8.
62. Niederman MS, Merrill WW, Polomski LM, Reynolds HY, Gee JB. Influence of sputum IgA and elastase on tracheal cell bacterial adherence. Am. Rev. Respir. Dis. 1986 133 : 255 60.
63. Fick RB Jr., Naegel GP, Squier SU, Wood RE, Gee JB et al. Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis. J. Clin. Invest. 1984 74 : 236 48.
64. Tsang KW, Chan K, Ho P, Zheng L, Ooi GC et al. Sputum elastase in steady-state bronchiectasis. Chest 2000 117 : 420 6.
65. Maisi P, Prikk K, Sepper R, Pirilä E, Salo T et al. Soluble membrane-type 1 matrix metalloproteinase (MT1-MMP) and gelatinase A (MMP-2) in induced sputum and bronchoalveolar lavage fluid of human bronchial asthma and bronchiectasis. APMIS 2002 110 : 771 82.
66. Stankovic M, Nikolic A, Divac A, Rakicevic L, Tomovic A et al. Matrix metalloproteinases gene variants in idiopathic disseminated bronchiectasis. J. Investig. Med. 2009 57 : 500 3.
67. Reid LM. Reduction in bronchial subdivision in bronchiectasis. Thorax 1950 5 : 233 47.
68. Cohen M, Sahn SA. Bronchiectasis in systemic diseases. Chest 1999 116 : 1063 74.
69. Ip M, So SY, Lam WK, Yam L, Liong E. High prevalence of asthma in patients with bronchiectalsis in Hong Kong. Eur. Respir. J. 1992 5 : 418 23.
70. Nicotra MB, Rivera M, Dale AM, Shepherd R, Carter R. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest 1995 108 : 955 61.
71. Onadeko BO, Kolawole TM. The clinical and aetiological pattern of finger clubbing and hypertrophic osteoarthropathy in Nigerians. Trop. Geogr. Med. 1979 31 : 191 9.
72. O'Brien C, Guest PJ, Hill SL, Stockley RA. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2000 55 : 635 42.
73. Patel IS, Vlahos I, Wilkinson TM, Lloyd-Owen SJ, Donaldson GC et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2004 170 : 400 7.
74. Rutland J, Cole PJ. Nasal mucociliary clearance and ciliary beat frequency in cystic fibrosis compared with sinusitis and bronchiectasis. Thorax 1981 36 : 654 8.
75. Efrati O, Harash O, Rivlin J, Bibi H, Meir MZ et al. Hemoptysis in Israeli CF patients - prevalence, treatment, and clinical characteristics. J. Cyst. Fibros. 2008 7 : 301 6.
76. Barker AF. Bronchiectasis. N. Engl. J. Med. 2002 346 : 1383 93.
77. Naidich DP, McCauley DI, Khouri NF, Stitik FP, Siegelman SS. Computed tomography of bronchiectasis. J. Comput. Assist. Tomogr. 1982 6 : 437 44.
78. Grenier P, Maurice F, Musset D, Menu Y, Nahum H. Bronchiectasis: assessment by thin-section CT. Radiology 1986 161 : 95 9.
79. Young K, Aspestrand F, Kolbenstvedt A. High resolution CT and bronchography in the assessment of bronchiectasis. Acta Radiol. 1991 32 : 439 41.
80. Giron J, Skaff F, Maubon A, Garnier T, Serres-Cousiné O et al. Millimetric-section x-ray computed tomography in the diagnosis and evaluation of bronchiectasis. Comparison with bronchography apropos of 54 patients. Ann. Radiol. (Paris) 1988 31 : 25 33.
81. Paslawski M, Zlomaniec J. Small bronchiectases and bronchiolectases in high-resolution computer tomography (HRCT). Ann. Univ. Mariae Curie Sklodowska [Med 2003 58 : 402 6.
82. Chang AB, Boyce NC, Masters IB, Torzillo PJ, Masel JP. Bronchoscopic findings in children with non-cystic fibrosis chronic suppurative lung disease. Thorax 2002 57 : 935 8.
83. Mansour Y, Beck R, Danino J, Bentur L. Resolution of severe bronchiectasis after removal of long-standing retained foreign body. Pediatr. Pulmonol. 1998 25 : 130 2.
84. Bertolani MF, Marotti F, Bergamini BM, Pellegrino M, Balli R et al. Extraction of a rubber bullet from a bronchus after 1 year: complete resolution of chronic pulmonary damage. Chest 1999 115 : 1210 13.
85. Ernst KD, Mahmud F. Reversible cystic dilatation of distal airways due to foreign body. South. Med. J. 1994 87 : 404 6.
86. Tsang KW, Tipoe G, Sun J, Tan KC, Leung R et al. Clinical value of ciliary assessment in bronchiectasis. Lung 2005 183 : 73 86.
87. Bush A, O'Callaghan C. Primary ciliary dyskinesia. Arch. Dis. Child. 2002 87 : 363 4, discussion 364-5.
88. Tsang KW, Leung R, Fung PC, Chan SL, Tipoe GL et al. Exhaled and sputum nitric oxide in bronchiectasis: correlation with clinical parameters. Chest 2002 121 : 88 94.
89. Balfour-Lynn IM, Laverty A, Dinwiddie R. Reduced upper airway nitric oxide in cystic fibrosis. Arch. Dis. Child. 1996 75 : 319 22.
90. MacCormick J, Robb I, Kovesi T, Carpenter B. Optimal biopsy techniques in the diagnosis of primary ciliary dyskinesia. J. Otolaryngol. 2002 31 : 13 17.
91. Tsang KW, Chan WM, Ho PL, Chan KN, Lam WK et al. A comparative study on use of empirical levofloxacin versus ceftazidime in the treatment of exacerbation of bronchiectasis. Eur. Respir. J. 1999 14 : 1206 9.
92. Tsang KW, Tan KC, Ho PL, Ooi GC, Ho JC et al. Inhaled fluticasone in bronchiectasis: a 12 month study. Thorax 2005 60 : 239 43.
93. Tsang KW, Tan KC, Ho PL, Ooi GC, Khong PL et al. Exhaled nitric oxide in bronchiectasis: the effects of inhaled corticosteroid therapy. Int. J. Tuberc. Lung Dis. 2004 8 : 1301 7.
94. Chan SL, Chan-Yeung MM, Ooi GC, Lam CL, Cheung TF et al. Validation of the Hong Kong Chinese version of the St. George Respiratory Questionnaire in patients with bronchiectasis. Chest 2002 122 : 2030 7.
95. Pang J, Chan HS, Sung JY. Prevalence of asthma, atopy and bronchial hyperactivity in bronchiectasis: a controlled study. Thorax 1989 44 : 948 51.
96. Bhalla M, Turcios N, Aponte V, Jenkins M, Leitman BS et al. Cystic fibrosis: scoring system with thin-section CT. Radiology 1991 179 : 783 8.
97. Ooi GC, Khong PL, Chan-Yeung M, Ho JC, Chan PK et al. High-resolution CT quantification of bronchiectasis: clinical and functional correlation. Radiology 2002 225 : 663 72.
98. Roberts HR, Wells AU, Milne DG, Rubens MB, Kolbe J et al. Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax 2000 55 : 198 204.
99. Cartier Y, Kavanagh PV, Johkoh T, Mason AC, Müller NL. Bronchiectasis: accuracy of high-resolution CT in the differentiation of specific diseases. AJR Am. J. Roentgenol. 1999 173 : 47 52.
100. Smith IE, Jurriaans E, Diederich S, Ali N, Shneerson JM et al. Chronic sputum production: correlations between clinical features and findings on high resolution computed tomographic scanning of the chest. Thorax 1996 51 : 914 18.
101. Laurenzi GA, Potter RT, Kass EH. Bacteriologic flora of the lower respiratory tract. N. Engl. J. Med. 1961 265 : 1273 8.
102. Angrill J, Agustí C, De Celis R, Filella X, Rañó A et al. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Am. J. Respir. Crit. Care Med. 2001 164 : 1628 32.
103. King P, Holdsworth S, Freezer N, Holmes P. Bronchiectasis. Intern. Med. J. 2006 36 : 729 37.
104. Høiby N. Antibodies against Pseudomonas aeruginosa in patients with bronchiectasis: helpful or harmful? Thorax 2001 56 : 667 8.
105. Wickremasinghe M, Ozerovitch LJ, Davies G, Wodehouse T, Chadwick MV et al. Non-tuberculous mycobacteria in patients with bronchiectasis. Thorax 2005 60 : 1045 51.
106. Fowler SJ, French J, Screaton NJ, Foweraker J, Condliffe A et al. Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics. Eur. Respir. J. 2006 28 : 1204 10.
107. Kunst H, Wickremasinghe M, Wells A, Wilson R. Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis. Eur. Respir. J. 2006 28 : 352 7.
108. Tanaka E, Amitani R, Niimi A, Suzuki K, Murayama T et al. Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease. Am. J. Respir. Crit. Care Med. 1997 155 : 2041 6.
109. Thomson RM, Yew WW. When and how to treat pulmonary non-tuberculous mycobacterial diseases. Respirology 2009 14 : 12 26.
110. Han D, Lee KS, Koh WJ, Yi CA, Kim TS et al. Radiographic and CT findings of nontuberculous mycobacterial pulmonary infection caused by Mycobacterium abscessus. AJR Am. J. Roentgenol. 2003 181 : 513 17.
111. Annest LS, Kratz JM, Crawford FA Jr. Current results of treatment of bronchiectasis. J. Thorac. Cardiovasc. Surg. 1982 83 : 546 50.
112. Roles FC, Todd GS. Bronchiectasis. Diagnosis and prognosis in relation to treatment. Bronchiectasis Med. J. 1993 2 : 639 43.
113. Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 2003 290 : 2301 12.
114. O'Neill B, Bradley JM, McArdle N, MacMahon J. The current physiotherapy management of patients with bronchiectasis: a UK survey. Int. J. Clin. Pract. 2002 56 : 34 5.
115. Phillips GE, Pike SE, Jaffe A, Bush A. Comparison of active cycle of breathing and high-frequency oscillation jacket in children with cystic fibrosis. Pediatr. Pulmonol. 2004 37 : 71 5.
116. Bateman JR, Newman SP, Daunt KM, Sheahan NF, Pavia D et al. Is cough as effective as chest physiotherapy in the removal of excessive tracheobronchial secretions? Thorax 1981 36 : 683 7.
117. Sutton PP, Parker RA, Webber BA, Newman SP, Garland N et al. Assessment of the forced expiration technique, postural drainage and directed coughing in chest physiotherapy. Eur. J. Respir. Dis. 1983 64 : 62 8.
118. Jones A, Rowe BH. Bronchopulmonary hygiene physical therapy in bronchiectasis and chronic obstructive pulmonary disease: a systematic review. Heart Lung 2000 29 : 125 35.
119. O'Donnell AE, Barker AF, Ilowite JS, Fick RB. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. Chest 1998 113 : 1329 34.
120. CDC. Prevention of pneumococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly Rep. 1997 46 : 1 24.
121. Whitney CG. Preventing pneumococcal disease. ACIP recommends pneumococcal polysaccharide vaccine for all adults age ≥65. Geriatrics 2003 58 : 20 2, 25.
122. Jackson LA, Neuzil KM, Yu O, Benson P, Barlow WE et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N. Engl. J. Med. 2003 348 : 1747 55.
123. World Health Organisation. Influenza vaccines. Wkly Epidemiol. Rec. 2002 77 : 230 9.
124. Gacouin A, Desrues B, Léna H, Quinquenel ML, Dassonville J et al. Long-term nasal intermittent positive pressure ventilation (NIPPV) in sixteen consecutive patients with bronchiectasis: a retrospective study. Eur. Respir. J. 1996 9 : 1246 50.
125. Etienne T, Spiliopoulos A, Megevand R. Bronchiectasis: indication and timing for surgery. Ann. Chir. 1993 47 : 729 35.
126. Mazières J. Limited operation for severe multisegmental bilateral bronchiectasis. Ann. Thorac. Surg. 2003 75 : 382 7.
127. Balkanli K, Genç O, Dakak M, Gürkök S, Gözübüyük A et al. Surgical management of bronchiectasis: analysis and short-term results in 238 patients. Eur. J. Cardiothorac. Surg. 2003 24 : 699 702.
128. Griesenbach U, Geddes DM, Alton EW. Update on gene therapy for cystic fibrosis. Curr. Opin. Mol. Ther. 2003 5 : 489 94.
129. Sheikh A, Nolan D, Greenstone M. Long-acting beta-2-agonists for bronchiectasis. Cochrane Database Syst. Rev. 2001 4 : CD002155.
130. Corless JA, Warburton CJ. Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis. Cochrane Database Syst. Rev. 2000 4 : CD002174.
131. Greenstone M, Rutman A, Dewar A, Mackay I, Cole PJ. Primary ciliary dyskinesia: cytological and clinical features. Q. J. Med. 1988 67 : 405 23.
132. Ip M, Lam WK, Chan J, Liong E. Systemic effects of airway inflammation in bronchiectasis. Respir. Med. 1991 85 : 521 5.
133. Ip M, Shum D, Lauder IJ, Lam WK, So SY. Effect of antibiotics on sputum inflammatory contents in acute exacerbations of bronchiectasis. Respir. Med. 1993 87 : 449 54.
134. Pines A. Controlled trials of a sulphonamide given weekly to prevent exacerbations of chronic bronchitis. BMJ 1967 3 : 202 4.
135. Stockley RA, Hill SL, Morrison HM. Effect of antibiotic treatment on sputum elastase in bronchiectatic outpatients in a stable clinical state. Thorax 1984 39 : 414 19.
136. Hill SL, Burnett D, Hewetson KA, Stockley RA. The response of patients with purulent bronchiectasis to antibiotics for four months. Q. J. Med. 1988 66 : 163 73.
137. Kelly CA, Stenton C, Gould K, Hendrick DJ. The effect of high-dose amoxycillin on bronchial responsiveness and symptoms in patient with bronchiectasis. Am. Rev. Respir. Dis. 1987 135 : A269.
138. Cole PJ. Bronchiectasis. In : Brewis RAL, Corrin B, Geddes DM, Gibson GJ (eds) Respiratory Medicine. Saunders, London, 1995 1286 317.
139. Evans D, Bara A, Greenstone M. Prolonged antibiotics for purulent bronchiectasis. Cochrane Database Syst. Rev. 2003 4 : CD001392.
140. Barker AF, Couch L, Fiel SB, Gotfried MH, Ilowite J et al. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am. J. Respir. Crit. Care Med. 2000 162 : 481 5.
141. Steinfort DP, Steinfort C. Effect of long-term nebulized colistin on lung function and quality of life in patients with chronic bronchial sepsis. Intern. Med. J. 2007 37 : 495 8.
142. Drobnic ME, Suñé P, Montoro JB, Ferrer A, Orriols R. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa. Ann. Pharmacother. 2005 39 : 39 44.
143. Couch LA. Treatment with tobramycin solution for inhalation in bronchiectasis patients with Pseudomonas aeruginosa. Chest 2001 120 (Suppl. 3 S114 17.
144. Orriols R, Roig J, Ferrer J, Sampol G, Rosell A et al. Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa. Respir. Med. 1999 93 : 476 80.
145. Bilton D, Henig N, Morrissey B, Gotfried M. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. Chest 2006 130 : 1503 10.
146. Rubin BK. Aerosolized antibiotics for non-cystic fibrosis bronchiectasis. J. Aerosol. Med. Pulm. Drug Deliv. 2008 21 : 71 6.
147. Currie DC, Garbett ND, Chan KL, Higgs E, Todd H et al. Double-blind randomized study of prolonged higher-dose oral amoxycillin in purulent bronchiectasis. Q. J. Med. 1990 76 : 799 816.
148. Khaliq Y, Zhanel GG. Musculoskeletal injury associated with fluoroquinolone antibiotics. Clin. Plast. Surg. 2005 32 : 495 502, vi.
149. Greenberger PA. Allergic bronchopulmonary aspergillosis. J. Allergy Clin. Immunol. 2002 110 : 685 92.
150. Lasserson TJ, Holt K, Milan SJ, Greenstone M. Oral steroids for bronchiectasis (stable and acute exacerbations). Cochrane Database Syst. Rev. 2001 2 : CD002162.
151. Barnes NC. Safety of high-dose inhaled corticosteroids. Respir. Med. 1993 87 (Suppl. A S27 31.
152. Elborn JS, Johnston B, Allen F, Clarke J, McGarry J et al. Inhaled steroids in patients with bronchiectasis. Respir. Med. 1992 86 : 121 4.
153. Yang IA, Fong KM, Sim EH, Black PN, Lasserson TJ. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2007 2 : CD002991.
154. Schiøtz PO, Jørgensen M, Flensborg EW, Faerø O, Husby S et al. Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. A longitudinal study of immune complex activity and inflammatory response in sputum sol-phase of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infections: influence of local steroid treatment. Acta Paediatr. Scand. 1983 72 : 283 7.
155. van Haren EH, Lammers JW, Festen J, Heijerman HG, Groot CA et al. The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis. Respir. Med. 1995 89 : 209 14.
156. Nikolaizik WH, Schöni MH. Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis. J. Pediatr. 1996 128 : 271 4.
157. Pantin CF, Stead RJ, Hodson ME, Batten JC. Prednisolone in the treatment of airflow obstruction in adults with cystic fibrosis. Thorax 1986 41 : 34 8.
158. Auerbach HS, Williams M, Kirkpatrick JA, Colten HR. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet 1985 2 : 686 8.
159. Eigen H, Rosenstein BJ, FitzSimmons S, Schidlow DV. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. J. Pediatr. 1995 126 : 515 23.
160. Greally P, Hussain MJ, Vergani D, Price JF. Interleukin-1 alpha, soluble interleukin-2 receptor, and IgG concentrations in cystic fibrosis treated with prednisolone. Arch. Dis. Child. 1994 71 : 35 9.
161. Shinkai M, Rubin BK. Macrolides and airway inflammation in children. Paediatr. Respir. Rev. 2005 6 : 227 35.
162. Bush A, Rubin BK. Macrolides as biological response modifiers in cystic fibrosis and bronchiectasis. Semin. Respir. Crit. Care Med. 2003 24 : 737 48.
163. Tsang KW, Ho PI, Chan KN, Ip MS, Lam WK et al. A pilot study of low-dose erythromycin in bronchiectasis. Eur. Respir. J. 1999 13 : 361 4.
164. Tagaya E, Tamaoki J, Kondo M, Nagai A. Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion. Chest 2002 122 : 213 18.
165. Yalçin E, Kiper N, Ozçelik U, Doru D, Firat P et al. Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis. J. Clin. Pharm. Ther. 2006 31 : 49 55.
166. Tanaka E, Kanthakumar K, Cundell DR, Tsang KW, Taylor GW et al. The effect of erythromycin on Pseudomonas aeruginosa and neutrophil mediated epithelial damage. J. Antimicrob. Chemother. 1994 33 : 765 75.
167. Tsang KW, Rutman A, Tanaka E, Lund V, Dewar A et al. Interaction of Pseudomonas aeruginosa with human respiratory mucosa in vitro. Eur. Respir. J. 1994 7 : 1746 53.
168. Goswami SK, Kivity S, Marom Z. Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro. Am. Rev. Respir. Dis. 1990 141 : 72 8.
169. Marom Z, Shelhamer JH, Kaliner M. Human pulmonary macrophage-derived mucus secretagogue. J. Exp. Med. 1984 159 : 844 60.
170. Anderson R. Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation. J. Infect. Dis. 1989 159 : 966 73.
171. Takeshita K, Yamagishi I, Harada M, Otomo S, Nakagawa T et al. Immunological and anti-inflammatory effects of clarithromycin: inhibition of interleukin 1 production of murine peritoneal macrophages. Drugs Exp. Clin. Res. 1989 15 : 527 33.
172. Ichikawa Y, Ninomiya H, Koga H, Tanaka M, Kinoshita M et al. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Am. Rev. Respir. Dis. 1992 146 : 196 203.
173. Wozniak DJ, Keyser R. Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa. Chest 2004 125 (Suppl. 2 S62 9.